Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  9, 27 - 32 (2002)
Published online: 23 December 2002; | doi:10.1038/nm806

Therapeutic dendritic-cell vaccine for simian AIDS

Wei Lu1, Xiaoxian Wu3, Yaozeng Lu3, Weizhong Guo3 & Jean-Marie Andrieu1, 2

1  Institut de Recherche sur les Vaccins et l'Immunothérapie des Cancers et du Sida, Paris, France

2  Laboratoire d'Oncologie et Virologie Moléculaire, Centre Biomédical des Saints-Pères, Université René Descartes (Paris V), Paris, France

3  Laboratory of Pathology and Virology, Tropical Medicine Institute, Guangzhou, P. R. China

Correspondence should be addressed to Wei Lu louis.wei-lu@biomedicale.univ-paris5.fr
An effective immune response against human immunodeficiency virus or simian immunodeficiency virus (SIV) is critical in achieving control of viral replication. Here, we show in SIV-infected rhesus monkeys that an effective and durable SIV-specific cellular and humoral immunity is elicited by a vaccination with chemically inactivated SIV-pulsed dendritic cells. After three immunizations made at two-week intervals, the animals exhibited a 50-fold decrease of SIV DNA and a 1,000-fold decrease of SIV RNA in peripheral blood. Such reduced viral load levels were maintained over the remaining 34 weeks of the study. Molecular and cellular analyses of axillary and inguinal node lymphocytes of vaccinated monkeys revealed a correlation between decreased SIV DNA and RNA levels and increased SIV-specific T-cell responses. Neutralizing antibody responses were augmented and remained elevated. Inactivated whole virus-pulsed dendritic cell vaccines are promising means to control diseases caused by immuno- deficiency viruses.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

NEWS AND VIEWS
Immunotherapy for AIDS virus infections: Cautious optimism for cell-based vaccine
Nature Medicine News and Views (01 Jan 2003)

RESEARCH
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef
Nature Medicine Article (01 Nov 1999)
Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection
Nature Medicine Article (01 May 2002)
MHC-I-restricted presentation of HIV-1 virion antigens without viral replication
Nature Medicine Article (01 Mar 2001)
Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
Nature Letters to Editor (21 Sep 2000)
 See all 5 matches for Research

 Top
Abstract
Previous | Next
Table of contents
Full textFull text
Download PDFDownload PDF
Send to a friendSend to a friend

Open Innovation Challenges

naturejobs

Figures & Tables
See also: News and Views by Bhardwaj & Walker
Export citation
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©2003 Nature Publishing Group | Privacy policy